Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:01 pm Purchase | 13G | FORWARD PHARMA A/S SPONSORED A FWP | Rosetta Capital I LP | 5,296,510 5.3% | 5,296,510 (New Position) | View |
| 2022-12-29 4:04 pm Purchase | 13G | FORWARD PHARMA A/S SPONSORED A FWP | StepStone Group LP | 13,709,598 13.8% | 13,709,598 (New Position) | View |
| 2022-02-14 12:59 pm Sale | 13G | FORWARD PHARMA A/S SPONSORED A FWP | BIOTECHNOLOGY VALUE FUND L P | 7,193,088 7.3% | -3,001,698 (-29.44%) | View |
| 2021-02-16 4:28 pm Sale | 13G | FORWARD PHARMA A/S SPONSORED A FWP | Newtyn Management LLC | 0 0% | -426,700 (Position Closed) | View |
| 2021-02-11 5:18 pm Sale | 13G | FORWARD PHARMA A/S SPONSORED A FWP | BIOTECHNOLOGY VALUE FUND L P | 10,194,786 10.7% | -3,897,950 (-27.66%) | View |
| 2020-02-14 4:10 pm Purchase | 13G | FORWARD PHARMA A/S SPONSORED A FWP | Newtyn Management LLC | 426,700 6.3% | 426,700 (New Position) | View |
| 2020-02-14 2:56 pm Purchase | 13G | FORWARD PHARMA A/S SPONSORED A FWP | BIOTECHNOLOGY VALUE FUND L P | 14,092,736 14.8% | 14,092,736 (New Position) | View |